SELLAS Life Sciences
15 hedge funds and large institutions have $720K invested in SELLAS Life Sciences in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
36% more funds holding
Funds holding: 11 → 15 (+4)
1.8% less ownership
Funds ownership: 7.99% → 6.19% (-1.8%)
57% less capital invested
Capital invested by funds: $1.67M → $720K (-$952K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$85.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$50.1K |
| 3 |
Bank of New York Mellon
New York
|
+$41.5K |
| 4 |
WG
Winton Group
London,
United Kingdom
|
+$20.2K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$3.05K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$178K |
| 2 |
LI
Leap Investments
Chicago,
Illinois
|
-$47K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.78K |
SLS Hedge Fund Activity: Q1 2020 in Review
15 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in SELLAS Life Sciences (SLS) for Q1 2020, worth a combined $720K — down 57% from $1.67M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new SLS positions and 2 closed out — a net gain of 5 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $85.4K. The largest seller was Oxford Asset Management, exiting entirely with an estimated $178K sold.
- 15 institutional investors held SELLAS Life Sciences (SLS) as of Q1 2020, up from 11 in Q4 2019.
- Funds reported $720K of SELLAS Life Sciences stock for Q1 2020, down 57% quarter-over-quarter.
- 7 funds opened new SELLAS Life Sciences positions in Q1 2020 and 2 closed out, a net change of +5 holders.
- The largest SELLAS Life Sciences buyer in Q1 2020 was Morgan Stanley, an estimated $85.4K added.
- The largest SELLAS Life Sciences seller in Q1 2020 was Oxford Asset Management, an estimated $178K sold.
Based on aggregated 13F filings for Q1 2020.